237 related articles for article (PubMed ID: 32434109)
1. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
2. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
3. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
[TBL] [Abstract][Full Text] [Related]
4. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States.
Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer.
Matsuo K; Matsuzaki S; Miller H; Nusbaum DJ; Walia S; Matsuzaki S; Shimada M; Klar M; Roman LD
J Surg Oncol; 2021 Sep; 124(4):687-698. PubMed ID: 34118157
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
[TBL] [Abstract][Full Text] [Related]
7. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
[TBL] [Abstract][Full Text] [Related]
11. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
Tang X; Li N; Hu Y
Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
[TBL] [Abstract][Full Text] [Related]
14. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD
J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055
[TBL] [Abstract][Full Text] [Related]
15. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
16. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes.
Multinu F; Garzon S; Weaver AL; McGree ME; Sartori E; Landoni F; Zola P; Dinoi G; Aletti G; Block MS; Gadducci A; Mariani A
Int J Gynecol Cancer; 2021 Apr; 31(4):537-544. PubMed ID: 33608453
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
19. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
20. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
